GlassScriptPhysician profile
Jamal M Bullocks
NPI 1134249451
$8,347.64
in general payments reported to CMS, 2019-2025
24 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,867 · 2020: $1,040 · 2021: $1,426 · 2022: $1,917 · 2023: $1,079 · 2024: $556 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $2,074.90 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $1,368.70 | 2019-2024 | Phasix Mesh |
| Sientra, INC. | $797.45 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $606.47 | 2019-2020 | |
| Galderma Laboratories, L.P. | $537.63 | 2021-2024 | Dysport |
| Zimmer Biomet Holdings, INC. | $436.34 | 2019-2025 | Traumaone |
| Allergan, INC. | $429.41 | 2019-2022 | |
| Tela Bio, INC. | $271.72 | 2019-2024 | Ovitex 2s |
| Medtronic, INC. | $235.47 | 2022-2024 | V-Loc 180 |
| Abbvie INC. | $205.45 | 2023-2024 | |
| Revance Therapeutics, INC. | $200.30 | 2024 | Daxxify |
| Mml US, INC. | $186.92 | 2022 | |
| Integra Lifesciences Corporation | $184.31 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Stryker Corporation | $176.97 | 2020-2025 | Optablate, Omnicurve |
| Relievant Medsystems, INC. | $160.29 | 2023 | Intracept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $160.25 | 2022 | |
| Tepha INC | $143.00 | 2019 | |
| Baxter Healthcare | $47.01 | 2019 | |
| Avanos Medical | $31.94 | 2019 | |
| Seqirus USA INC | $27.54 | 2025 | Flucelvax |
| Apyx Medical Corporation | $24.19 | 2020 | |
| Wound Management Technologies, INC | $16.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.35 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamal Bullocks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.